School of Health & Sport Sciences, University of Brighton, Eastbourne, UK.
School of Architecture, Technology and Engineering, University of Brighton, Brighton, UK.
Musculoskeletal Care. 2024 Sep;22(3):e1924. doi: 10.1002/msc.1924.
Musculoskeletal (MSK) conditions affect over 20.3 million people in the UK, presenting a substantial economic impact on health and social services. Physiotherapy can alleviate MSK conditions, especially if delivered in the acute or sub-acute period. However, patients often present after significant waiting times.
Our analysis examined how waiting times and the number of treatments influenced physiotherapy outcomes for MSK conditions.
Retrospective analysis of the Data for Impact, Physio First dataset.
Logistic regression models assessed the effects of symptom duration, treatment frequency, and other variables on pain, Patient-Specific Functional Scores (PSFSs), and Goal Achievement (GA).
Analysis of 15,624 patient records showed that patients treated within two weeks of symptom onset were more likely to have favourable outcomes in pain (odds ratio [OR] = 2.01, 95% Confidence Interval [95% CI] = 1.65-2.45), PSFS (OR = 1.80, 95% CI = 1.55-2.08), and GA (OR = 1.74, 95% CI = 1.51-2.01) compared to those treated after longer durations. Receiving four or more treatment sessions significantly improved outcomes compared with only one session (pain: OR = 4.64, PSFS: OR = 5.72, GA: OR = 1.94, all p's < 0.001), with no additional benefits beyond four sessions. Younger age was associated with better outcomes (approximately OR = 0.99 per year age difference). Other findings included better outcomes in males and in those with fewer previous episodes of the condition.
Shorter waiting times, a greater number of treatments, and younger patient age are associated with better physiotherapy outcomes for MSK conditions.
肌肉骨骼(MSK)疾病影响了英国超过 2030 万人,对医疗和社会服务造成了巨大的经济影响。物理疗法可以缓解 MSK 疾病,尤其是在急性或亚急性阶段进行治疗时。然而,患者通常在等待很长时间后才就诊。
我们的分析研究了等待时间和治疗次数如何影响 MSK 疾病的物理治疗效果。
对 Data for Impact,Physio First 数据集进行回顾性分析。
使用逻辑回归模型评估了症状持续时间、治疗频率和其他变量对疼痛、患者特定功能评分(PSFS)和目标达成(GA)的影响。
对 15624 名患者记录的分析表明,在症状出现后两周内接受治疗的患者在疼痛(优势比 [OR] = 2.01,95%置信区间 [95%CI] = 1.65-2.45)、PSFS(OR = 1.80,95%CI = 1.55-2.08)和 GA(OR = 1.74,95%CI = 1.51-2.01)方面更有可能获得良好的结果,与在更长时间后接受治疗的患者相比。与仅接受一次治疗相比,接受四次或更多次治疗可显著改善结果(疼痛:OR = 4.64,PSFS:OR = 5.72,GA:OR = 1.94,所有 p 值均 < 0.001),但四次以上治疗并无额外获益。年龄较小与更好的结果相关(年龄每增加 1 岁,结果约改善 OR = 0.99)。其他发现包括男性和该病发作次数较少的患者的结果更好。
较短的等待时间、更多的治疗次数和更年轻的患者年龄与 MSK 疾病的更好的物理治疗效果相关。